GSK to get less from Zhifei shingles vaccine deal; to collaborate on RSV
By Yadarisa Shabong (Reuters) -China’s Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK’s shingles vaccine in China, the UK drugmaker said on Thursday, lower than previously agreed though the deal has been extended. The deal also now includes exclusive rights for China’s largest vaccine company to …
GSK to get less from Zhifei shingles vaccine deal; to collaborate on RSV Read More »